Viewing Study NCT03363334


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-01-06 @ 10:20 PM
Study NCT ID: NCT03363334
Status: NO_LONGER_AVAILABLE
Last Update Posted: 2018-08-01
First Post: 2017-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Expanded Access of Fostamatinib in Patients With Persistent or Chronic Relapsing/Refractory ITP
Sponsor: Rigel Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module